Skip to content

Clinical trials

Completed Multiple Endocrine Neoplasia Type 1 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Status: Completed Country / region: United States Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20062
20072
20081
20094
20103
20113
20121
20132
20144
20154
20161
20172
20187
20193
20201
20212
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arizona State University2
Bayer2
Florida State University2
Medical College of Wisconsin2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Ohio State University Comprehensive Cancer Center2
Premier Research2
Albert Einstein College of Medicine1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 150
Breast Neoplasms5
Obesity4
Prostatic Neoplasms4
Weight Loss4
Acquired Immunodeficiency Syndrome2
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
HIV Infections2
Hot Flashes2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.